In simple terms, ZIM Laboratories Limited has 48.726 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.506% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.091%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.052%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.057% return, is a testament to ZIM Laboratories Limited's adeptness in optimizing resource deployment. ZIM Laboratories Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.101%. Furthermore, the proficiency of ZIM Laboratories Limited in capital utilization is underscored by a remarkable 0.148% return on capital employed.
Stock Prices
ZIM Laboratories Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $133.15, while its low point bottomed out at $126.25. This variance in figures offers investors a lucid insight into the roller-coaster ride that is ZIM Laboratories Limited's stock market.
ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.